{"data":[{"accessionNo":"0001172661-26-003572","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":405092,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001172661-26-003572","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":405092,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-003073","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-06-30","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":51866,"percentOfClass":1.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-003073","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-06-30","reportingPerson":"Lind Global Fund III LP","reportingCik":null,"personType":"PN","sharesOwned":49366,"percentOfClass":1.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-003073","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-06-30","reportingPerson":"Lind Global Partners III LLC","reportingCik":null,"personType":"OO","sharesOwned":49366,"percentOfClass":1.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-26-037652","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value per share","eventDate":"2026-06-30","reportingPerson":"Waqas Khatri","reportingCik":null,"personType":"IN","sharesOwned":111145,"percentOfClass":2.93,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-26-037652","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value per share","eventDate":"2026-06-30","reportingPerson":"Ayrton Capital LLC","reportingCik":null,"personType":"IA","sharesOwned":111145,"percentOfClass":2.93,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-26-037652","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value per share","eventDate":"2026-06-30","reportingPerson":"Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B","reportingCik":null,"personType":"CO","sharesOwned":111145,"percentOfClass":2.93,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-001905","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":161232,"percentOfClass":7.87,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-001905","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Lind Global Fund III LP","reportingCik":null,"personType":"PN","sharesOwned":158732,"percentOfClass":7.76,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-001905","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":"29405E505","securityClass":"Common Stock, $0.01 par value","eventDate":"2026-03-31","reportingPerson":"Lind Global Partners III LLC","reportingCik":null,"personType":"OO","sharesOwned":158732,"percentOfClass":7.76,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-000500","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2026-01-28","reportingPerson":"Lind Global Fund III LP","reportingCik":null,"personType":"PN","sharesOwned":141265,"percentOfClass":9.99,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-000500","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2026-01-28","reportingPerson":"Lind Global Partners III LLC","reportingCik":null,"personType":"OO","sharesOwned":141265,"percentOfClass":9.99,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-000500","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2026-01-28","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":141265,"percentOfClass":9.99,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-26-010971","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-27","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":71246,"percentOfClass":4.99,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-26-010971","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-27","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":71246,"percentOfClass":4.99,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-26-010971","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-27","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":71246,"percentOfClass":4.99,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-12-31","reportingPerson":"AdvisorShares Trust","reportingCik":null,"personType":"IV","sharesOwned":16974,"percentOfClass":1.66,"filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-123020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-11","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":31353,"percentOfClass":4.99,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-123020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-11","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":31353,"percentOfClass":4.99,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-123020","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-11","reportingPerson":"INTRACOASTAL CAPITAL, LLC","reportingCik":null,"personType":"OO","sharesOwned":31353,"percentOfClass":4.99,"filedAt":"2025-12-17","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-120055","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-09","reportingPerson":"Braeden Lichti","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-120056","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-09","reportingPerson":"Braeden Lichti","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-120056","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-09","reportingPerson":"Northstrive Fund II LP","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-120055","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-09","reportingPerson":"Northstrive Fund II LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-118848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-03","reportingPerson":"Braeden Lichti","reportingCik":null,"personType":"IN","sharesOwned":29920,"percentOfClass":5.01,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-118884","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-03","reportingPerson":"Braeden Lichti","reportingCik":null,"personType":"PN","sharesOwned":29920,"percentOfClass":5.01,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-118848","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-03","reportingPerson":"Northstrive Fund II LP","reportingCik":null,"personType":"PN","sharesOwned":25915,"percentOfClass":4.34,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-118884","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-12-03","reportingPerson":"Northstrive Fund II LP","reportingCik":null,"personType":"IN","sharesOwned":25915,"percentOfClass":4.34,"filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-25-022260","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Waqas Khatri","reportingCik":null,"personType":"IN","sharesOwned":658465,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-25-022260","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Ayrton Capital LLC","reportingCik":null,"personType":"IA","sharesOwned":658465,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001493152-25-022260","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"ENVERIC BIOSCIENCES, INC.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value per share","eventDate":"2025-09-30","reportingPerson":"Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B","reportingCik":null,"personType":"CO","sharesOwned":658465,"percentOfClass":9.99,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0000929638-25-003807","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-09-30","reportingPerson":"AdvisorShares Trust","reportingCik":null,"personType":"IV","sharesOwned":203679,"percentOfClass":6.27,"filedAt":"2025-10-03","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-091199","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-18","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":19333,"percentOfClass":0.4,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-091199","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-18","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":19333,"percentOfClass":0.4,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/envb"},{"accessionNo":"0001213900-25-091199","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000890821","issuerName":"Enveric Biosciences, Inc.","ticker":"ENVB","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-18","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":19333,"percentOfClass":0.4,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/envb"}],"updatedAt":"2026-11-03T17:40:57.039Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/envb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}